MedPeer Inc
F:9UN

Watchlist Manager
MedPeer Inc Logo
MedPeer Inc
F:9UN
Watchlist
Price: 999 999.9999 EUR
Market Cap: €21.7T

Wall St Price Targets

9UN Price Targets Summary
MedPeer Inc

There are no price targets for 9UN.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
MedPeer Inc Competitors:
Price Targets

Revenue
Forecast

43% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
43% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -2%.

Gross Profit
Forecast

38% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
38% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 38%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for MedPeer Inc

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 9UN's stock price target?
Not Available

9UN does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for MedPeer Inc?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -2%.

Back to Top